Bi-level Positive Airway Pressure for Respiratory Distress Syndrome in Twins Infants

NCT03235661 — Not applicable, Unknown, 300 participants, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Bi-level Positive Airway Pressure for Respiratory Distress Syndrome in Twins:A Randomized Controlled Trials

RegistryNCT03235661
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: quadruple, treatment
Enrollment300 (Estimated)
SponsorDaping Hospital and the Research Institute of Surgery of the Third Military Medical University (Other)
ConditionsnCPAP, BiPAP, Respiratory Distress Syndrome
InterventionsBiPAP, nCPAP (Device)
Datesstart 2017-08-15, primary completion 2022-12-15 (estimated), completion 2022-12-15 (estimated), first posted 2017-08-01, last updated 2021-02-16
Locations1 site in China

Related Papers Related Patents Related Grants Related Experts
All trials for nCPAP All trials for BiPAP All trials of BiPAP All trials of nCPAP

-Summary

The investigators compared advantages and disadvantages of two forms of noninvasive respiratory support -bi-level positive airway pressure(BiPAP) or nasal continuous positive airway pressure (nCPAP) -as a primary mode of ventilation in preterm twins infants with respiratory distress syndrome

Expand all sections  ·  Collapse all

+Detailed description

Invasive ventilation is related to development of adverse pulmonary and nonpulmonary outcomes in ventilated infants. Various modes of noninvasive respiratory support are being increasingly used to minimize the incidence of bronchopulmonary dysplasia (BPD). The aim of this trial to compare the effects of bi-level positive airway pressure(BiPAP) and nasal continuous positive airway pressure (NCPAP) in preterm twins infants as the primary mode.

+Arms and interventions

ArmTypeInterventionsDescription
BiPAPExperimentalDevice: BiPAPBiPAP as a primary mode of ventilation in one of the preterm infants with respiratory distress syndrome
nCPAPActive comparatorDevice: nCPAPnCPAP is used as a primary mode of ventilation in another of the preterm infants with respiratory distress syndrome
  • BiPAP (Device): BiPAP is used as a primary mode of ventilation in one of the preterm infants with respiratory distress syndrome
  • nCPAP (Device): nCPAP is used as a primary mode of ventilation in another of the preterm infants with respiratory distress syndrome

+Outcome measures

Primary outcomes

  • intubation rate [within 7 days]: the baby was intubated

+Eligibility

Sex: All, ages: 5 Minutes to 6 Hours

Inclusion Criteria:

* 1\. Gestational age (GA) is from 26 to 37 weeks;
* 2\. Diagnosis of respiratory distress syndrome. The diagnosis of respiratory distress syndrome will be based on clinical manifestations (tachypnea, nasal flaring and or grunting) and chest X-ray findings;
* 3\. Respiratory distress syndrome Silverman score >5;
* 4\. Informed parental consent has been obtained.

Exclusion Criteria:

* 1\. Severe respiratory distress syndrome requiring early intubation according to the American Academy of Pediatrics guidelines for neonatal resuscitation;
* 2\. Major congenital malformations or complex congenital heart disease;
* 3\. Group B hemolytic streptococcus pneumonia, septicemia, pneumothorax, pulmonary hemorrhage;
* 4\. Cardiopulmonary arrest needing prolonged resuscitation;
* 5\. transferred out of the neonatal intensive care unit without treatment.

+Locations (1)

FacilityCityCountryStatus
Department of Pediatrics, Daping Hospital, Third Military Medical UniversityChongqing, Chongqing MunicipalityChinaRecruiting

+Investigators

  • Shi Yuan, PhD,MD, Study director, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University